mg/day by the Agency for Toxic Substances and Disease Registry (ATSDR) in the United States (Ge et al., 2007) .
A series of animal studies has suggested reproductive toxicity of DEHP including endocrine-disrupting properties. In female rats, 12-day treatment with 2,000 mg/kg body weight/day of DEHP decreases estradiol synthesis, prolongs the estrus cycle, and causes anovulation (Davis et al., 1994) , and 4-week treatment with 3,000 mg/kg body weight/day increases irregular estrous cycles and prolongs mean estrous cycles (Takai et al., 2009) . Additionally, there are some reports about reproductive toxicity of mono-(2-ethylhexyl) phthalate (MEHP), which is the active and most toxic metabolite of DEHP (Pollack et al., 1985) , based on studies using cultured granulosa cells from rat ovaries (Lovekamp and Davis, 2001; . Some of these reports showed that MEHP decreased estradiol synthesis (Lovekamp and Davis, 2001; in isolated rat granulosa cells, which is consistent with the results of the 12-day treatment with DEHP to female rats (Davis et al., 1994) . Although cultured granulosa cells provide new insights to endocrine disorders induced by MEHP, the results are not directly applicable to evaluation of the effects of MEHP on the follicular organization and entire synthetic pathway of steroid hormones, because the culture system of isolated granulosa cells includes neither theca cells nor oocytes. Further, progesterone is known to be converted into androstenedione only in theca cells in the ovarian follicles.
Since cultured ovarian follicles are composed of theca cells, granulosa cells, and oocytes, it is considered that the potential ovarian toxicity of chemicals on the follicular organization and entire synthetic pathway of steroid hormones can be evaluated in a short time with a small amount of the chemicals. The present study was conducted to evaluate the effects of MEHP on the follicular development and steroid hormone synthesis using cultured rat ovarian follicles.
MATERIALS AND METHODS

Reagents
MEHP was purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Dimethyl sulfoxide (DMSO) was purchased from Research Organics, Inc. (Cleveland, OH, USA). Alpha-minimum essential medium (α-MEM) and Leibovitz's L-15 (L-15) medium were purchased from DS Pharma Biomedical Co., Ltd. (Osaka, Japan). Collagenase Type I-A, deoxyribonuclease I (DNase), albumin from bovine serum (BSA), 8-bromoguanosine 3',5'-cyclic monophosphate sodium salt monohydrate (8-Br-cGMP), FSH from human pituitary (hFSH), insulin-transferrin-selenium +1 liquid media supplement (ITS), and penicillin-streptomycin solution were purchased from Sigma-Aldrich, Inc. (Tokyo, Japan).
Animals
All experimental procedures were approved by the Institutional Animal Care and Use Committee of Dainippon Sumitomo Pharma Co., Ltd. (Osaka, Japan). Fourteenday-old female Sprague-Dawley rats (Crl:CD(SD) rats) were obtained from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). The rats were used for the experiment immediately after receipt.
Isolation and culture of ovarian follicles
Ovarian follicles were isolated and cultured using techniques reported previously (McGee et al., 1997; Rose et al., 1999; Wang et al., 2003; Fowler and Spears, 2004) . The female rats were euthanized by decapitation and the ovaries were collected aseptically into sterilized phosphate buffered saline (PBS). The ovaries were incubated with shaking at 37ºC for 30 min in α-MEM supplemented with 4 mg/ml collagenase and 0.02% (w/v) DNase. After incubation, the ovaries were transferred into L-15 medium supplemented with 3 mg/ml BSA, and secondary follicles (< 180 μm in diameter) were manually dissected using 25-gauge needles in the medium. Ovarian follicles with normal morphological appearance were individually pre-cultured in Millicell-CM culture plate inserts (PICM 01250; Nihon Millipore K.K., Tokyo, Japan) with 300 μl α-MEM supplemented with 1 mg/ml BSA, 5 mM 8-Br-cGMP, 100 ng/ml hFSH, 1% (w/v) ITS and 1% (w/v) penicillin-streptomycin solution at 37ºC in a humidified atmosphere of 5% CO 2 and 95% air for 24 hr. After pre-culture, intact follicles were selected, the follicular diameters were measured under an inverted microscope (original magnification, 400 ×) using an objective micrometer (OB-M, 1/100; Olympus Corporation, Tokyo, Japan) precalibrated for microscope digital camera system (DP12; Olympus Corporation), and they were allocated to four groups. After allocation, 180 μl of used medium was exchanged for fresh medium supplemented with MEHP (final concentrations: 0 μg/ml for control group; and 10, 30, and 100 μg/ml in 0.1% (v/v) DMSO), and the follicles were cultured under the same conditions as described above for additional 48 hr (the MEHP treatment period). After 24 hr of MEHP treatment, medium exchanges were conducted.
Follicular development and viability of ovarian follicles
Follicular diameters were measured at 0, 24, and 48 hr of the MEHP treatment period using the objective micrometer as described above. After 48 hr of MEHP treatment, cultured follicles were stained with 0.08% (w/v) trypan blue (Gibco 0.4% (w/v) Trypan Blue Stain; Life Technologies Japan Ltd., Tokyo, Japan) at room temperature for 5 min (Demirci et al., 2001) . They were washed in PBS, and the trypan blue-positive cells were observed using an inverted microscope (original magnification, 400 ×). Ovarian follicles with less than 10 trypan blue-positive cells were classifi ed as normal follicles, and those with 10 or more trypan blue-positive cells were classifi ed as damaged follicles (Myllymaki et al., 2005) .
To evaluate apoptosis using TUNEL assay, cultured ovarian follicles were fi xed and preserved in 10% (w/v) neutral buffered formalin after the trypan blue staining. They were stained with hematoxylin, embedded in agar, further embedded in paraffi n, and sectioned at 2 μm thickness. TUNEL staining of the sections was conducted using a TUNEL assay kit (ApopTag Peroxidase In Situ Apoptosis Detection Kit; Nihon Millipore K.K., Tokyo, Japan).
Steroid hormone assay
After 48 hr of MEHP treatment, the medium was individually sampled and stored at -80ºC. Progesterone, testosterone, and estradiol levels in the medium were measured with EIA kits (Progesterone EIA Kit, Testosterone EIA Kit, and Estradiol EIA Kit, respectively; Cayman Chemical Company, Ann Arbor, MI, USA). An androstenedione level in the medium was measured with an ELISA kit (Androstenedione ELISA Kit; IBL Hamburg GmbH, Hamburg, Germany). Progesterone, androstenedione, testosterone, and estradiol levels in each medium were combined to evaluate the effects of MEHP on synthetic pathway from cholesterol to progesterone, including de novo synthesis of cholesterol. Progesterone/androstenedione, androstenedione/testosterone, and testosterone/estradiol ratios were calculated to evaluate the effects of MEHP on the respective conversions.
Statistical analyses
Data obtained for follicular development and steroid hormone assays are presented as means ± S.D. Data for the follicular development were analyzed using Tukey's test for multiple comparisons. Data for the steroid hormone assays were analyzed using Dunnett's and Steel's tests in the homogeneous and heterogeneous cases, respectively, after testing homogeneity of variance in the data by Bartlett's test. Differences were considered statistically signifi cant for p < 0.05.
RESULTS
Effects of MEHP on follicular development
At the initiation of MEHP treatment, the follicular diameters were 196.0 ± 12. 8, 195.5 ± 14.5, 197.2 ± 12.4, and 195 .5 ± 9.6 μm (n = 6 per group) in the control, and MEHP 10, 30, and 100 μg/ml groups, respectively (Fig. 1) . In the control, and MEHP 10 and 30 μg/ml groups, the follicles developed time-dependently during the treatment period. In the MEHP 100 μg/ml group, however, the follicular development was suppressed at 24 and 48 hr of the treatment period, and the follicular diameter was significantly lower compared to other groups after 48 hr of treatment.
Effects of MEHP on viability of ovarian follicles
Trypan blue-positive cells were detected in granulosa layers, but not in theca layers. All the ovarian follicles in the control, and MEHP 10 and 30 μg/ml groups were classifi ed as normal follicles (Table 1) . In the MEHP 100 μg/ml group, however, all the follicles were classifi ed as damaged follicles.
In the TUNEL assay, few TUNEL-positive granulosa cells were found in the ovarian follicles in the control, or MEHP 10 or 30 μg/ml group ( Figs. 2A-C) . In the MEHP 100 μg/ml group, however, TUNEL-positive granulosa cells were found in the follicles (Fig. 2D) . 
Effects of MEHP on steroid hormone synthesis
Progesterone levels in the media increased in all the MEHP treatment groups, with statistical significance in the 30 and 100 μg/ml groups (p < 0.05) compared to the control group (Fig. 3A) . Androstenedione, testosterone, and estradiol levels increased or tended to increase with concentrations in the MEHP 10 and 30 μg/ml groups (Figs. 3B-D) . However, androstenedione, testosterone, and estradiol levels were significantly lower (p < 0.05, 0.01, and 0.05, respectively) in the MEHP 100 μg/ml group than in the control group. Combined steroid hormone levels calculated by summing the levels of progesterone, androstenedione, testosterone, and estradiol were signifi cantly higher in the MEHP 10, 30, and 100 μg/ml groups (p < 0.05, 0.001, and 0.001, respectively) than in the control group (Fig. 3E) .
To evaluate the effects of MEHP on conversion from progesterone to estradiol, progesterone/androstenedione, androstenedione/testosterone, and testosterone/estra- Number of damaged follicles Control MEHP 10 μg/ml MEHP 30 μg/ml MEHP 100 μg/ml 6 / 6 6 / 6 6 / 6 0 / 6 0 / 6 0 / 6 0 / 6 6 / 6
Rat ovarian follicles were cultured with MEHP (0, 10, 30, and 100 μg/ml), and stained with trypan blue at 48 hr of the MEHP treatment period. Follicles with less than 10 trypan blue-positive cells were classifi ed into normal follicles, and those with 10 or more trypan blue-positive cells into damaged follicles.
Fig. 2.
Effects of MEHP on follicular viability in cultured rat ovarian follicles by TUNEL assay. Rat ovarian follicles were cultured with MEHP (0, 10, 30, and 100 μg/ml), and TUNEL assay of the ovarian follicles was conducted at 48 hr of the MEHP treatment period. (A) the ovarian follicle cultured with MEHP 0 μg/ml, (B) 10 μg/ml, (C) 30 μg/ml, or (D) 100 μg/ml. Original magnifi cation is 400 ×. Bar is presented as 100 μm. TUNEL-positive granulosa cells in the ovarian follicles cultured with MEHP 100 μg/ml (D) are indicated (arrowheads).
diol ratios were calculated ( Table 2 ). The progesterone/ androstenedione ratio significantly increased in the MEHP 30 and 100 μg/ml groups (p < 0.05) compared to the control group, and in particular the ratio in the 100 μg/ml group was approximately 84-fold higher than that in the control group. On the other hand, MEHP showed no significant effect on androstenedione/testosterone or testosterone/estradiol ratio in any MEHP treatment group. 
DISCUSSION
In the present study, MEHP at all concentrations increased the combined steroid hormone levels of progesterone, androstenedione, testosterone, and estradiol. This change implies that MEHP activates the synthetic pathway from cholesterol to progesterone, including de novo synthesis of cholesterol, in the cultured rat ovarian follicles. MEHP has been found to increase progesterone and testosterone synthesis by increasing the amount of cholesterol for steroid hormone synthesis accompanied with the up-regulation of hormone-sensitive lipase (HSL) and 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase (HMGCR) in immortalized mouse Leydig tumor cells, MLTC-1 (Gunnarsson et al., 2008) , and to activate the peroxisome proliferator-activated receptor (PPAR) α and PPARγ in human breast cancer cells, MCF-7 (Venkata et al., 2006) . It has been reported that the activation of PPARα increases the expression of HMGCR (Le Jossic-Corcos et al., 2004) and the activation of PPARγ increases the expression of HSL (Deng et al., 2006) .
The progesterone, androstenedione, testosterone, and estradiol levels increased or tended to increase at 10 and 30 μg/ml MEHP. On the other hand, at 100 μg/ml, the progesterone level increased, but the androstenedione, testosterone, and estradiol levels decreased. At this concentration, the progesterone/androstenedione ratio markedly increased, but there was no change in the androstenedione/testosterone or testosterone/estradiol ratio. The remarkable increase in the progesterone/androstenedione ratio at 100 μg/ml suggests that MEHP strongly inhibits the conversion from progesterone to androstenedione. Therefore, it is considered that the decrease in androstenedione, testosterone, and estradiol synthesis at 100 μg/ml is attributable to the inhibitory effects of MEHP on the conversion from progesterone to androstenedione. The metabolism of progesterone into androstenedione has been known to be catalyzed by P450c17, and MEHP has been reported to reduce P450c17 mRNA levels in MLTC-1 cells (Gunnarsson et al., 2008) . Taken together, the suppression of androstenedione, testosterone, and estradiol synthesis at 100 μg/ml might be attributable to the inhibition of P450c17 activity, but not to the inhibition of 17β-hydroxysteroid dehydrogenase (17β-HSD) or aromatase (P450arom), which converts from androstenedione to testosterone or from testosterone to estradiol, respectively. As described above, MEHP showed the biphasic effects on steroid hormone synthesis in the cultured rat ovarian follicles with increases or tendencies toward increases in androstenedione, testosterone, and estradiol synthesis at 10 and 30 μg/ml, and decreases at 100 μg/ml. The similar biphasic effects of MEHP on steroid hormone synthesis are observed in primary cultured rat Leydig cells with an increase in testosterone at 100 μM (equivalent to 30 μg/ml) and a decrease at 10 mM (equivalent to 3 mg/ml) (Ge et al., 2007) .
MEHP at 100 μg/ml suppressed follicular development, and the suppression was accompanied with low viability of cultured rat ovarian follicles and apoptosis of granulosa cells. One possible mechanism underlying the apoptosis might be related to the decrease in estradiol synthesis, because it has been reported that apoptosis of granulosa cells is inhibited by estrogens (Kaipia and Hsueh, 1997; Quirk et al., 2006) and incidence of apoptosis of granulosa cells is related to decreased estradiol synthesis in bovine follicles (Valdez et al., 2005) . In the present study, MEHP at 100 μg/ml strongly decreased estradiol synthesis. Therefore, it is considered that the apoptosis of granulosa cells at 100 μg/ml is attributable to the decrease in estradiol synthesis. Moreover, the suppression of follicular development and the apoptosis of granulosa cells observed in the present study are consistent with the results of DEHP treatment of female rats that had small preovulatory follicles accompanied with suppressed estradiol production (Davis et al., 1994) . Rat ovarian follicles were cultured with MEHP (0, 10, 30, and 100 μg/ml). Individual progesterone, androstenedione, testosterone and estradiol levels in the media were measured at 48 hr of the MEHP treatment period, and progesterone/androstenedione (PROG/AND), androstenedione/testosterone (AND/TEST) and testosterone/estradiol (TEST/EST) ratios were calculated. The data are presented as means ± S.D. # ; Significantly different from control, p < 0.05 (Steel's test).
MEHP induced the histopathological changes in cultured rat ovarian follicles that had been observed in female rats treated with DEHP (Davis et al., 1994) . In the rats, progesterone and estradiol synthesis decreased. In the present study, a high concentration of MEHP decreased estradiol synthesis, but increased progesterone synthesis. There is a discrepancy in progesterone synthesis between the female rats treated with DEHP and the cultured rat ovarian follicles with MEHP. In the rats, the decrease in progesterone synthesis was accompanied with an increase in serum FSH level and an absence of LH surge, and thus it is considered that the possible mechanism underlying the decrease in progesterone synthesis involves the effects on the feedback system in the hypothalamic-pituitary-ovarian axis. The cultured rat ovarian follicles reflect the direct effects of MEHP on steroid hormone synthesis without any effects through the hypothalamic-pituitaryovarian axis.
In conclusion, MEHP induced ovarian toxicity via suppression of follicular development accompanied with apoptosis of granulosa cells and abnormal steroid hormone synthesis including decreased estradiol synthesis in the cultured rat ovarian follicles. These results show that we can evaluate the direct effects of chemicals on the ovarian morphology, including follicular development and histopathological change, and on the overall synthetic pathway of steroid hormones, without respect to the feedback system in the hypothalamic-pituitary-ovarian axis, in a short time with a small amount of chemical using this method. Thus, the method using cultured rat ovarian follicles is considered useful to evaluate the potential ovarian toxicity of chemicals including medicinal products.
